Motrin Articles
Successful POM To OTC Switching In The UK
27 February 1995
FDA Regulations On Drug Promotion
13 February 1995
UK POM To OTC: Analysis Of Success
12 December 1994
Good Half-year For Boots But No News On Pharma
7 November 1994
Unfolding Change In The French OTC Market
31 October 1994
European Sales of OTC Analgesics To 2000
24 October 1994
WHAT FUTURE FOR STERLING HEALTH
4 July 1994
BOOTS FOCUSES ON OTC AND EUROPE
4 July 1994
THE CHANGING US ANALGESIA MARKET
27 June 1994
BOOTS LOOKING MORE TO THE OTC SECTOR
13 June 1994
SELF-MEDICATION IN EUROPE: 1994 EDITION
21 March 1994
UK PRESCRIBING STUDY "WOULD RAISE COSTS"
14 March 1994
CYSTIC FIBROSIS; WHAT COMES AFTER PULMOZYME?
7 March 1994
CIBA LAUNCHES CATAFLAM NSAID IN USA
31 January 1994
Rx-TO-OTC SWITCHES IN THE USA
6 December 1993
MUSCULOSKELETAL MARKET TO DECLINE
6 December 1993
WILL CHIROS FLOAT TO THE TOP?
15 November 1993
MARKET WARMS TO COUGH & COLD SEASON IN USA
1 November 1993
STERLING CUTS ASPIRIN PRICE
11 October 1993
ASPIRIN AND IBUPROFEN IN HEAVY DRINKERS
27 September 1993
EUROPEAN ANALGESIC MARKET
27 September 1993
IBUPROFEN OFF DRUGS LIST IN JAPAN
2 August 1993
BOOTS CONSIDERS DRUG DIV FUTURE
2 August 1993
MISOPROSTOL PRAISED AT ILAR
26 July 1993
DELISTING AND OTC SALES IN DENMARK
26 July 1993
SMITHKLINE BEECHAM CORPORATE OTC STRATEGY
5 July 1993
INDIA: A PATENT REGIME FOR DRUG SECURITY
21 June 1993
NEW YORK STOCK COMMENT
14 June 1993
BOOTS HOPES TO SWAY CITY WITH RESULTS
7 June 1993
ZYMA LAUNCHES OTC PROFLEX
31 May 1993
UK OTC SALES UP 10% IN 1992 BY VOLUME
24 May 1993
ADAPTING TO HEALTH CARE REFORM THE SB WAY
17 May 1993
SELLING TO THE UK HEALTH SERVICE
17 May 1993
BOOTS BUYS ITALIAN AND FRENCH FIRMS
10 May 1993
US PRODUCT NEWS IN BRIEF
25 January 1993
US OTC ANALGESICS - A 1992 RETROSPECTIVE
4 January 1993
SWITCHING POM TO OTC IN THE UK
14 December 1992
UNLICENSING drugs AND OFF-LABEL PRESCRIBING
14 December 1992
SETON HEALTHCARE ACQUIRES CUPAL
7 December 1992
SUCCESSFUL POM-TO-P SWITCHES IN THE UK
9 November 1992
RX-TO-OTC SWITCHING FOR SUCCESS
2 November 1992
FOCUS ON IVAX PRODUCT PIPELINE
12 October 1992
UK OTC MEDICINES MARKET GROWTH
12 October 1992
PROBLEMS IN APPROVING EURO OTC MONOGRAPHS
3 August 1992
COPROMOTION DEAL FOR ZOVIRAX IN USA
8 June 1992
INDIAN IBUPROFEN CHARGE DROPPED
6 April 1992
INDIAN IBUPROFEN CHARGE DROPPED
6 April 1992
SELF-MEDICATION IN EUROPE IN THE 1990s
23 March 1992
LABS LIADE BECOMES BOOTS PHARMA
27 January 1992
US CHARGES INDIA WITH DUMPING
13 January 1992
PHARMACISTS WANT THIRD DRUG CLASS
13 January 1992
ANALGESICS IN THE USA -- AN OPEN DOOR FOR P&G?
6 January 1992
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
